Relmada Therapeutics Inc
NASDAQ:RLMD
During the last 3 months Relmada Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 54% over this period (open performance analysis).
The last transaction was made on
Dec 15, 2025
by
Shenouda Maged
, who
bought
48.1k USD
worth of 
RLMD shares.
During the last 3 months Relmada Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 54% over this period (open performance analysis).
The last transaction was made on
Dec 15, 2025
by
Shenouda Maged
, who
bought
48.1k USD
worth of RLMD shares.
Relmada Therapeutics Inc
Glance View
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The company is headquartered in Coral Gables, Florida and currently employs 10 full-time employees. The company went IPO on 2014-03-03. The firm is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), which is an N-methyl-D-aspartate (NMDA) receptor antagonist. The Company’s lead product candidate, esmethadone, is a new chemical entity (NCE) developed as a rapidly acting, oral agent for the treatment of depression, central nervous system (CNS) diseases and other potential indications. The Company’s lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission and is in development for both the adjunctive or monotherapy treatment of major depressive disorder (MDD).
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
